Several studies have revealed that SPOP inhibited the progression of PC by promoting the degradation of various oncoproteins, such as androgen receptor [40], steroid receptor coactivator 3 [41], and Myc [42]. The gene discussed is MYC; the disease is pachyonychia congenita.